Percentage values are from United States statistics 2004. Subtype specific incidences are taken from Table 6 (invasive) and Table 3 (in situ) from Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC (Junio de 2009). «The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999–2004». Cancer Epidemiol. Biomarkers Prev.18 (6): 1763-1769. PMID19454615. doi:10.1158/1055-9965.EPI-08-1082.. These are divided by total breast cancer incidence (211,300 invasive and 55,700 in situ cases) as reported from Breast Cancer Facts & Figures 2003–2004 «Archived copy». Archivado desde el original el 15 de abril de 2009. Consultado el 15 de junio de 2010.
cancer.org
Percentage values are from United States statistics 2004. Subtype specific incidences are taken from Table 6 (invasive) and Table 3 (in situ) from Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC (Junio de 2009). «The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999–2004». Cancer Epidemiol. Biomarkers Prev.18 (6): 1763-1769. PMID19454615. doi:10.1158/1055-9965.EPI-08-1082.. These are divided by total breast cancer incidence (211,300 invasive and 55,700 in situ cases) as reported from Breast Cancer Facts & Figures 2003–2004 «Archived copy». Archivado desde el original el 15 de abril de 2009. Consultado el 15 de junio de 2010.
doi.org
dx.doi.org
Percentage values are from United States statistics 2004. Subtype specific incidences are taken from Table 6 (invasive) and Table 3 (in situ) from Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC (Junio de 2009). «The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999–2004». Cancer Epidemiol. Biomarkers Prev.18 (6): 1763-1769. PMID19454615. doi:10.1158/1055-9965.EPI-08-1082.. These are divided by total breast cancer incidence (211,300 invasive and 55,700 in situ cases) as reported from Breast Cancer Facts & Figures 2003–2004 «Archived copy». Archivado desde el original el 15 de abril de 2009. Consultado el 15 de junio de 2010.
Subramanian, J; Govindan R (February 2007). «Lung cancer in never smokers: a review». Journal of Clinical Oncology25 (5): 561-570. PMID17290066. doi:10.1200/JCO.2006.06.8015.
Percentage values are from United States statistics 2004. Subtype specific incidences are taken from Table 6 (invasive) and Table 3 (in situ) from Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC (Junio de 2009). «The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999–2004». Cancer Epidemiol. Biomarkers Prev.18 (6): 1763-1769. PMID19454615. doi:10.1158/1055-9965.EPI-08-1082.. These are divided by total breast cancer incidence (211,300 invasive and 55,700 in situ cases) as reported from Breast Cancer Facts & Figures 2003–2004 «Archived copy». Archivado desde el original el 15 de abril de 2009. Consultado el 15 de junio de 2010.
Subramanian, J; Govindan R (February 2007). «Lung cancer in never smokers: a review». Journal of Clinical Oncology25 (5): 561-570. PMID17290066. doi:10.1200/JCO.2006.06.8015.
Percentage values are from United States statistics 2004. Subtype specific incidences are taken from Table 6 (invasive) and Table 3 (in situ) from Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC (Junio de 2009). «The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999–2004». Cancer Epidemiol. Biomarkers Prev.18 (6): 1763-1769. PMID19454615. doi:10.1158/1055-9965.EPI-08-1082.. These are divided by total breast cancer incidence (211,300 invasive and 55,700 in situ cases) as reported from Breast Cancer Facts & Figures 2003–2004 «Archived copy». Archivado desde el original el 15 de abril de 2009. Consultado el 15 de junio de 2010.